利妥昔单抗 T9910

Product Introduction
Bioactivity


英文名: Rituximab

描述: Rituximab 是抗 CD20 嵌合单克隆抗体，用于研究某些自身免疫疾病和癌症。

细胞实验: Objective: Complement-mediated cell lysis. Concentrations: 0, 0.02, 0.2, 2, 20 μg/mL. Incubation Time: 2 h. Method: Lymphoma B cells were purified from lymph node biopsies of patients with B-cell lymphoma. Rituximab was added to tumor cells (1×106 /mL) in complete medium supplemented by human serum, inactivated or not by incubation at 56°C for 30 minutes. After 2 hours at 37°C, cell lysis was determined by PI staining of cells and analysis by flow cytometry.

存储条件: store at low temperaturestore at -20°C

关键字: Rituximab

利妥昔单抗 T9910信息由TargetMol中国为您提供，如您想了解更多关于利妥昔单抗 T9910报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途